The acquisition, announced today, will see Globus Medical buy all outstanding shares of Nevro for $5.85 each. The transaction price is a 27% premium over Nevro's 90-day volume-weighted average ...

April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

2025 Financial Guidance and Fourth-Quarter 2024 Earnings Conference Call and Webcast As previously announced on February 6, 2025, given the pending acquisition of Nevro by Globus Medical ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...